MCWF Helps Improve Pregnancy per Embryo Transfer in Dairy Recipients with One Lactation
An abstract has been presented at the 2023 AETA & CETA/ACTE Joint Convention in Orlando, FL summarizing a study showing a positive effect of MCWF (Amplimune) on pregnancy per embryo transfer for dairy cows with one lactation.
Positive Data from Endometrial Cups Study with Settle® Presented at International Symposium
Data from a U.S. study using NovaVive's immunotherapy for equine endometritis, Settle®, to treat endometrial cups was presented today at the International Symposium on Equine Reproduction (ISER) in Foz do Iguaçu, Brazil.
MCWF (Amplimune) Offers an Alternative for Herd Health as FDA Further Restricts Antibiotics
Effective in June, 2023, all over-the-counter bovine antibiotics in the U.S. will be switched to prescription-only status. Amplimune immunotherapy offers an alternative to antibiotics that does not require a prescription.